Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Antibody Targeting EGFR and LGR5, in Advanced HNSCC
Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecifi…
229 viewsMay 18, 2023
vumedi.com
Petosemtamab: um novo anticorpo contra o câncer
Petosemtamab: um novo anticorpo contra o câncer
1 week ago
terra.com.br
Dr Siu on the Rationale for Combining Petosemtamab With Pembrolizumab in HNSCC | OncLive
Dr Siu on the Rationale for Combining Petosemtamab With P…
Oct 4, 2024
onclive.com
Merus N.V.: Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC
Merus N.V.: Merus announces First Patient Dosed in Phase 2 Trial of P…
Dec 16, 2024
finanznachrichten.de
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus Pembrolizumab in HNSCC | OncLive
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizumab in Metastatic HNSCC | OncLive
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizum…
Jul 15, 2024
onclive.com
Les données intermédiaires de Merus sur le pétosemtamab démontrent une activité cliniquement significative dans le carcinome à cellules squameuses de la tête et du cou (CCSTC) précédemment traité
Les données intermédiaires de Merus sur le pétosemtamab démo…
Apr 18, 2023
zonebourse.com
8:21
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) T…
Jun 16, 2024
onclive.com
1:42
Everett E. Vokes, MD, FASCO, from UChicago Medicine presents interi…
60 viewsJan 6, 2025
FacebookOncLive
Petosemtamab Plus Pembrolizumab vs. Pembrolizumab Alone for Firs…
Sep 27, 2024
onclive.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
8 months ago
onclive.com
Merus and Halozyme Enter Global Collaboration and License Agree…
3 months ago
marketscreener.com
3:15
Phase II study of petosemtamab and pembrolizumab for recurrent/meta…
271 viewsJul 12, 2024
YouTubeVJOncology
1:59
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizum…
183 viewsJul 16, 2024
YouTubeOncLive
1:20
Comparing petosemtamab and pembrolizumab in HNSCC with exi…
204 viewsJul 12, 2024
YouTubeVJOncology
2:01
Petosemtamab has promising activity in advanced HNSCC
697 viewsApr 28, 2023
YouTubeVJOncology
5:31
ASCO Merus Petosemtamab (MCLA-158) pembro as 1L treatment (r/m) …
90 viewsAug 25, 2024
bilibiliDrSssssssss
Merus et Halozyme concluent un accord mondial de collaboration e…
3 months ago
zonebourse.com
9:58
Nature Medicine—亨廷顿病研究重磅突破：靶向于SEMA4D的抗体Pepi…
351 viewsAug 12, 2022
bilibili奇异脑博士
14:09
#pertuzumab | Uses, Dosage, Side Effects & Mechanism | Perjeta
1.8K viewsOct 26, 2023
YouTubeHe-InFo
Merus N.V.: Merus Announces Abstract Accepted for Presentatio…
10 months ago
finanznachrichten.de
4:02
Peptamen Mechanisms of Action
19.8K viewsMar 30, 2016
YouTubeNestlé Health Science Canada
4:06
Immunotherapy for Head and Neck Cancer Treatment
7.3K viewsNov 29, 2021
YouTubeJohns Hopkins Medicine
4:15
Bispecific antibodies in multiple myeloma: teclistamab, talquetama…
928 viewsNov 21, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:21
Overcoming PD-1-resistance in head and neck cancer with ADCs and b…
45 views2 months ago
YouTubeVJOncology
FDA Approves Kesimpta® (Ofatumumab), the First Self-Admi…
Aug 25, 2020
mymsaa.org
The Role of PharmDs in PEComa Care: Optimizing Treatment With …
53 views11 months ago
vumedi.com
1:16:37
Building on the Immunotherapy Foundation for Head and Neck Ca…
2.5K viewsJul 5, 2023
YouTubePeerView Oncology
ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Th…
221 viewsJun 6, 2024
vumedi.com
4:12
Immunotherapy for Cancer: Pembrolizumab #cancer #immuno…
13.3K viewsOct 13, 2022
YouTubeCancer Therapeutics
See more videos
Static thumbnail place holder